Deloitte · consulting-deck
Accelerated Access Review UK Mapping
109 pages · 3 arc beats · 2 loops
Accelerated Access Review UK Mapping
Deloitte arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
15101520253035404550556065707580859095100105109
Deck intelligence map
3 coverage by narrative range · generated from this deck JSON
Narrative range 105 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 5 slides 100% 5/5 slides 100% 5/5 slides · 41 hits — 0/5 slides
100% 5/5 slides 80% 4/5 slides 100% 5/5 slides 100% 5/5 slides Agitate (Make it worse) 11 slides 100% 11/11 slides 100% 11/11 slides · 60 hits — 0/11 slides
45.5% 5/11 slides · 6 hits 45.5% 5/11 slides · 6 hits 100% 11/11 slides 100% 11/11 slides Solution (Provide relief) 89 slides 100% 89/89 slides 100% 89/89 slides · 519 hits 3.4% 3/89 slides 30.3% 27/89 slides 48.3% 43/89 slides 100% 89/89 slides 100% 89/89 slides Slide inventory
109 every slide · same image gating as the playbook
05
The slide uses a two-part framework to categorize challenges, distinguishing between systemic/cross-cutting issues and those specific to certain sectors (pharmaframe_problem
06
The slide uses a list-based structure to detail specific barriers: stakeholder alignment, incentives, data/evidence, and culture.frame_problem
07
The slide uses a process-flow framework to categorize specific pain points.diagnose
08
The slide uses a process flow diagram to map specific pain points to development, regulation, reimbursement, and adoption stages.diagnose
09
CDx = co-diagnostics; Source: Stakeholder interviews, workshops and Deloitte analysisdiagnose
10
The slide uses a simple list-based framework to categorize 12 items into 3 groups of 4.prioritize
15
The diagram uses a flow-chart style to represent iterative loops and parallel processes within the pharmaceutical lifecycle.present_framework
16
The slide uses a process flow diagram to map the medical device lifecycle, highlighting key milestones like NICE routing and local patient access.present_framework
17
The slide uses a complex flow diagram to represent the regulatory and adoption pathway, mapping stages to time durations.present_framework
18
The slide uses a two-part framework (A and B) to define the scope of the analysis.front_matter
19
The slide uses a visual legend approach to map slide components to their descriptions.present_framework
21
The slide uses a process-flow framework to categorize specific barriers alongside cross-cutting organizational challenges.diagnose
23
The slide uses a complex flow diagram to differentiate development paths for three drug types.present_framework
24
The slide uses a simple icon-based list structure to present qualitative findings from stakeholder interviews.diagnose
25
The slide uses a hub-and-spoke diagram to connect stakeholder types to specific pain points.illustrate_case
26
The slide uses a 2x2 grid layout to categorize stakeholder feedback.diagnose
28
The slide uses a color-coded flow chart to distinguish between different product types (small molecules, biologics, vaccines) and their respective regulatory ropresent_framework
29
The slide uses a process-like icon header to indicate the regulatory stage.frame_problem
30
The slide uses a hub-and-spoke diagram to attribute quotes to different stakeholder groups (Industry, NHS, Charities, HMG/ALBs) via color-coding.illustrate_case
31
Uses a 2x2 grid layout to contrast different stakeholder viewpoints on regulatory processes.diagnose
33
The slide uses a color-coded flow chart to distinguish between different drug types and their respective evaluation processes (NICE vs. Commissioning).present_solution
34
The slide uses a list-based structure to detail specific industry-public sector friction points.frame_problem
35
Uses a hub-and-spoke diagram to connect stakeholder quotes to a central figure representing the patient or the system.illustrate_case
36
The slide uses a 2x2 matrix layout to contrast different stakeholder groups.diagnose
38
The diagram uses a flow-chart style to map decision points (committees, stakeholder engagement, formulary listing) leading to patient access. It distinguishes bpresent_framework
39
The slide uses a list-based structure to detail specific pain points identified through research.frame_problem
40
The slide uses a hub-and-spoke diagram to attribute quotes to different stakeholder groups (Industry, NHS, Charities, HMG/ALBs) via color-coding.illustrate_case
41
The slide uses a 2x2 grid layout to contrast different stakeholder viewpoints.frame_problem
43
The slide uses a three-column layout to structure the case study narrative.illustrate_case
45
The slide uses a process flow diagram to map specific pain points to development, regulation, reimbursement, and adoption stages.diagnose
47
The slide uses a multi-line color-coded system to represent different regulatory pathways for medical devices. It includes decision diamonds and iterative loopsplan_implementation
49
Uses a hub-and-spoke diagram to connect stakeholder quotes to a central user icon, with color-coding for different stakeholder groups.illustrate_case
50
The slide uses a 2x2 grid layout to contrast different stakeholder viewpoints.diagnose
52
The slide uses a color-coded line system to represent different regulatory paths based on device classification.present_framework
53
The slide uses a process-like header indicating this is part of a larger regulatory journey.diagnose
54
The slide uses color-coded speech bubbles to attribute quotes to different stakeholder groups (Industry, NHS, Charities, HMG/ALBs).illustrate_case
55
Uses a 2x2 grid layout to contrast different stakeholder viewpoints.diagnose
57
The slide uses a complex flow chart to map out different evaluation programs (MTEP, DAP, IPP, Single/Multiple Technology Appraisal) and their respective outcomepresent_framework
58
The slide uses a list-based structure to detail specific barriers related to NICE processes and industry capabilities.diagnose
59
Uses a hub-and-spoke diagram to connect stakeholder groups to specific feedback quotes.illustrate_case
60
Uses a 2x2 grid layout to categorize stakeholder feedback.diagnose
62
The slide uses a color-coded flow chart to represent different device classes and their respective adoption journeys.present_framework
63
The slide uses a list format with icons to categorize the five challenges.frame_problem
64
Uses a hub-and-spoke diagram to attribute quotes to different stakeholder groups (Industry, NHS, Charities, HMG/ALBs) via color-coding.illustrate_case
65
LHE = Local Health Economy; TAP = Technology Appraisal Programmediagnose
67
The slide uses a three-column layout to structure the case study narrative.illustrate_case
70
The slide uses a process flow diagram to map specific pain points to different stages of the diagnostic pathway.diagnose
72
The slide uses a multi-line color-coded system to represent different device classes. It includes decision diamonds and iterative loops.plan_implementation
73
The slide uses a list format to detail specific barriers for SMEs and the broader diagnostic market.frame_problem
74
The slide uses a hub-and-spoke diagram to connect stakeholder quotes to a central icon representing the industry/stakeholders.illustrate_case
75
The slide uses a 2x2 grid layout to contrast different stakeholder viewpoints.diagnose
77
The diagram uses color-coded lines to represent different product categories and their respective regulatory steps.present_framework
78
The slide uses a process-like icon header to indicate the current stage of the deck.frame_problem
79
Uses a hub-and-spoke diagram with color-coded speech bubbles to represent different stakeholder groups (Industry, NHS, Charities, HMG/ALBs).illustrate_case
80
The slide uses a 2x2 matrix layout to contrast different stakeholder viewpoints.diagnose
82
The slide uses a color-coded flow chart to represent different device categories and their respective evaluation processes.present_framework
83
The slide uses a list-based structure to detail specific systemic barriers in the UK healthcare reimbursement landscape.diagnose
84
Uses a hub-and-spoke diagram to attribute quotes to different stakeholder groups (Industry, NHS, Charities, HMG/ALBs).illustrate_case
85
The slide uses a 2x2 grid layout to categorize stakeholder feedback.diagnose
87
The slide uses a complex flowchart/process map to show how different device types navigate clinical champion uptake, business case development, and funding negopresent_framework
88
The slide uses a list-based structure to detail specific pain points related to market access, process efficiency, budget structures, and contracting.frame_problem
89
The slide uses a hub-and-spoke diagram to attribute quotes to different stakeholder groups (Industry, NHS, Charities, HMG/ALBs) via color-coding.illustrate_case
90
LHE = Local Health Economy; TAP = Technology Appraisal Programmediagnose
92
The slide uses a three-column structure to break down the case study into Background, Issues, and Challenges.illustrate_case
93
The slide uses a three-column layout to structure the case study narrative.illustrate_case
95
The slide uses a side-by-side comparison framework to contrast two distinct healthcare domains across three levels: pathway structure, stakeholder barriers, anddiagnose
96
TEC = Technology-Enabled Care; MHRA = Medicines and Healthcare products Regulatory Agency.present_framework
97
The slide uses a hub-and-spoke style diagram to represent stakeholder pain points feeding into a structured list of systemic barriers.diagnose
98
TEC = Technology-Enabled Careprioritize
99
The slide uses a process flow diagram to map the journey from development to local adoption, identifying specific bottlenecks and risks.diagnose
100
The slide uses a pyramid-like structure to categorize barriers into Standards, Regulation, Reimbursement, and Culture/Infrastructure.diagnose
103
The slide uses a 4x3 matrix structure to detail the research process.present_framework
104
The slide uses a process flow diagram to represent the product pathway and a collage of source documents to illustrate the methodology.present_framework
105
The slide outlines 6 distinct categories of medical devices with descriptions, examples, and color-coded keys.present_framework
106
The slide uses a color-coded legend to distinguish between interviewed and non-interviewed stakeholders.establish_context